首页 > 最新文献

Revista medica de Chile最新文献

英文 中文
[Suicidal Behavior in Chilean Adolescents: A Multidimensional Analysis Focused on Psychological, Clinical, and Socio-Familial Factors]. [智利青少年的自杀行为:心理、临床和社会家庭因素的多维分析]。
Pub Date : 2025-05-01 DOI: 10.4067/s0034-98872025000500362
Pablo Méndez-Bustos, Alejandra Tapia, Jorge Lopez-Castroman, Jaime Fuster-Villaseca

Suicidal behavior is a global public health issue, particularly among adolescents, where it stands as one of the leading causes of death in this age group. In Chile, adolescent suicide rates have alarmingly increased over recent decades, with psychological, clinical, and socio-familial factors emerging as key contributors. However, existing theoretical models face limitations when applied to specific sociocultural contexts.

Aim: To explain suicidal behavior in a clinical sample of Chilean adolescents, integrating psychological, clinical and socio-familial factors.

Methods: A non-experimental cross-sectional study was carried out in 388 adolescents (59.3% female; mean age: 15.63 years) admitted to the healthcare system in the Maule Region. Validated instruments were applied, including the BIS-11, DASS-21, DERS, ISI, GHSQ-V, and C-SSRS, to assess impulsivity, emotional regulation, anxious-depressive symptoms, and suicide risk. Multiple logistic regression models were fitted to identify significant predictors of suicidal ideation and attempts. Model quality was assessed through ROC analysis.

Results: For the suicidal ideation model, significant predictors included maternal responsiveness, depressive symptoms, family history of mental illness, prior hospitalization due to suicide attempts, and victimization through bullying and sexual abuse. In the suicidal attempt model, relevant factors were the absence of siblings, unplanned impulsivity, emotional interference, previous hospitalizations for mental health, suicidal ideation, and serious intent to attempt suicide. The models demonstrated adequate predictive performance with areas under the curve (AUC) of 0.89 and 0.94, respectively.

Conclusions: The findings highlight the multidimensional nature of adolescent suicidal behavior, revealing the interplay between individual and contextual factors. These models contribute to understanding the phenomenon and could guide targeted preventive interventions and public policies aimed at this vulnerable group. Expanding the analysis to different regions and populations is suggested to validate and enrich the results.

自杀行为是一个全球性的公共卫生问题,特别是在青少年中,它是这一年龄组死亡的主要原因之一。在智利,近几十年来青少年自杀率惊人地上升,心理、临床和社会家庭因素成为主要因素。然而,现有的理论模型在应用于特定的社会文化背景时存在局限性。目的:综合心理、临床和社会家庭因素,解释智利青少年临床样本中的自杀行为。方法:对388名青少年进行非实验横断面研究(女性59.3%;平均年龄:15.63岁)在Maule大区的医疗保健系统接受治疗。采用BIS-11、DASS-21、DERS、ISI、GHSQ-V和C-SSRS等经过验证的工具评估冲动性、情绪调节、焦虑抑郁症状和自杀风险。多元逻辑回归模型拟合以确定自杀意念和企图的显著预测因子。采用ROC分析评估模型质量。结果:对于自杀意念模型,显著的预测因子包括母亲反应性、抑郁症状、精神疾病家族史、自杀未遂住院史、欺凌和性虐待受害者。在自杀企图模型中,相关因素为兄弟姐妹的缺失、计划外的冲动、情绪干扰、先前的精神健康住院、自杀意念和严重的自杀意图。模型的曲线下面积(AUC)分别为0.89和0.94,具有较好的预测效果。结论:研究结果强调了青少年自杀行为的多维性,揭示了个体和环境因素之间的相互作用。这些模型有助于理解这一现象,并可以指导针对这一弱势群体的有针对性的预防性干预措施和公共政策。建议将分析扩展到不同的地区和人群,以验证和丰富结果。
{"title":"[Suicidal Behavior in Chilean Adolescents: A Multidimensional Analysis Focused on Psychological, Clinical, and Socio-Familial Factors].","authors":"Pablo Méndez-Bustos, Alejandra Tapia, Jorge Lopez-Castroman, Jaime Fuster-Villaseca","doi":"10.4067/s0034-98872025000500362","DOIUrl":"https://doi.org/10.4067/s0034-98872025000500362","url":null,"abstract":"<p><p>Suicidal behavior is a global public health issue, particularly among adolescents, where it stands as one of the leading causes of death in this age group. In Chile, adolescent suicide rates have alarmingly increased over recent decades, with psychological, clinical, and socio-familial factors emerging as key contributors. However, existing theoretical models face limitations when applied to specific sociocultural contexts.</p><p><strong>Aim: </strong>To explain suicidal behavior in a clinical sample of Chilean adolescents, integrating psychological, clinical and socio-familial factors.</p><p><strong>Methods: </strong>A non-experimental cross-sectional study was carried out in 388 adolescents (59.3% female; mean age: 15.63 years) admitted to the healthcare system in the Maule Region. Validated instruments were applied, including the BIS-11, DASS-21, DERS, ISI, GHSQ-V, and C-SSRS, to assess impulsivity, emotional regulation, anxious-depressive symptoms, and suicide risk. Multiple logistic regression models were fitted to identify significant predictors of suicidal ideation and attempts. Model quality was assessed through ROC analysis.</p><p><strong>Results: </strong>For the suicidal ideation model, significant predictors included maternal responsiveness, depressive symptoms, family history of mental illness, prior hospitalization due to suicide attempts, and victimization through bullying and sexual abuse. In the suicidal attempt model, relevant factors were the absence of siblings, unplanned impulsivity, emotional interference, previous hospitalizations for mental health, suicidal ideation, and serious intent to attempt suicide. The models demonstrated adequate predictive performance with areas under the curve (AUC) of 0.89 and 0.94, respectively.</p><p><strong>Conclusions: </strong>The findings highlight the multidimensional nature of adolescent suicidal behavior, revealing the interplay between individual and contextual factors. These models contribute to understanding the phenomenon and could guide targeted preventive interventions and public policies aimed at this vulnerable group. Expanding the analysis to different regions and populations is suggested to validate and enrich the results.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 5","pages":"362-372"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144319134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Use of Daratumumab, Carfilzomib and Pomalidomide in Patients with Relapsed Multiple Myeloma: A Current High-Efficacy Treatment]. [使用达拉单抗、卡非佐米和波马度胺治疗复发性多发性骨髓瘤:目前的一种高效治疗方法]。
Pub Date : 2025-04-01 DOI: 10.4067/s0034-98872025000400246
Francisco Samaniego E, Guillermo Conte L

Multiple myeloma (MM) is a malignancy derived from plasma cells. Advances in treatment have improved survival in MM patients; however, it remains incurable, and most patients will relapse. Rescue treatments based on daratumumab, carfilzomib, and pomalidomide have shown good results internationally, but there is a lack of data on their effectiveness and safety in Chile.

Aim: To evaluate the outcomes of these treatments in patients with relapsed or refractory multiple myeloma (RRMM) treated at the Clinical Hospital of the University of Chile.

Materials and methods: A retrospective descriptive study was conducted, including patients over 18 years of age with RRMM treated with regimens based on daratumumab, carfilzomib and/ or pomalidomide. Data were obtained from electronic medical records. The response rates, progression-free survival (PFS), overall survival (OS), and adverse events were analyzed.

Results: A total of 15 patients with RRMM were included, with a mean age of 67 years and an average of 3 prior treatment lines. Of the patients, 86.6% were refractory to lenalidomide, and 46.6% were refractory to both lenalidomide and bortezomib. The response rates were as follows: 6.6% stable disease, 26.6% partial response, 53.3% very good partial response, and 13.3% complete response. The median PFS was 20 months, and the OS was not reached. Four patients (26.6%) died-three from progression of the myeloma and one from infection. The most common adverse events were infections and infusion reactions. Treatments were well tolerated.

Conclusions: Rescue treatment with daratumumab, carfilzomib, and/or pomalidomide was shown to be effective and safe in heavily pretreated patients with RRMM. PFS and OS were favorable compared to international studies, although the responses were less deep. These results are relevant for advocating the inclusion of these medications in the national health guarantees program, where treatment options for RRMM are very limited.

多发性骨髓瘤是一种起源于浆细胞的恶性肿瘤。治疗的进步提高了MM患者的生存率;然而,它仍然无法治愈,大多数患者会复发。基于daratumumab、carfilzomib和pomalidomide的抢救治疗在国际上显示出良好的效果,但在智利缺乏其有效性和安全性的数据。目的:评价这些治疗在智利大学临床医院治疗的复发或难治性多发性骨髓瘤(RRMM)患者的疗效。材料和方法:进行了一项回顾性描述性研究,包括18岁以上的RRMM患者,采用基于达拉单抗、卡非佐米和/或泊马度胺的方案治疗。数据来自电子病历。分析有效率、无进展生存期(PFS)、总生存期(OS)和不良事件。结果:共纳入15例RRMM患者,平均年龄67岁,平均3个既往治疗线。86.6%的患者对来那度胺难治,46.6%的患者对来那度胺和硼替佐米均难治。有效率为:病情稳定6.6%,部分缓解26.6%,非常好部分缓解53.3%,完全缓解13.3%。中位PFS为20个月,未达到OS。4例(26.6%)患者死亡,其中3例死于骨髓瘤进展,1例死于感染。最常见的不良事件是感染和输液反应。治疗耐受性良好。结论:达拉单抗、卡非佐米和/或泊马度胺对重度预处理的RRMM患者的抢救治疗是有效和安全的。与国际研究相比,PFS和OS是有利的,尽管反应不那么深入。这些结果与倡导将这些药物纳入国家健康保障计划有关,因为在国家健康保障计划中,RRMM的治疗选择非常有限。
{"title":"[Use of Daratumumab, Carfilzomib and Pomalidomide in Patients with Relapsed Multiple Myeloma: A Current High-Efficacy Treatment].","authors":"Francisco Samaniego E, Guillermo Conte L","doi":"10.4067/s0034-98872025000400246","DOIUrl":"https://doi.org/10.4067/s0034-98872025000400246","url":null,"abstract":"<p><p>Multiple myeloma (MM) is a malignancy derived from plasma cells. Advances in treatment have improved survival in MM patients; however, it remains incurable, and most patients will relapse. Rescue treatments based on daratumumab, carfilzomib, and pomalidomide have shown good results internationally, but there is a lack of data on their effectiveness and safety in Chile.</p><p><strong>Aim: </strong>To evaluate the outcomes of these treatments in patients with relapsed or refractory multiple myeloma (RRMM) treated at the Clinical Hospital of the University of Chile.</p><p><strong>Materials and methods: </strong>A retrospective descriptive study was conducted, including patients over 18 years of age with RRMM treated with regimens based on daratumumab, carfilzomib and/ or pomalidomide. Data were obtained from electronic medical records. The response rates, progression-free survival (PFS), overall survival (OS), and adverse events were analyzed.</p><p><strong>Results: </strong>A total of 15 patients with RRMM were included, with a mean age of 67 years and an average of 3 prior treatment lines. Of the patients, 86.6% were refractory to lenalidomide, and 46.6% were refractory to both lenalidomide and bortezomib. The response rates were as follows: 6.6% stable disease, 26.6% partial response, 53.3% very good partial response, and 13.3% complete response. The median PFS was 20 months, and the OS was not reached. Four patients (26.6%) died-three from progression of the myeloma and one from infection. The most common adverse events were infections and infusion reactions. Treatments were well tolerated.</p><p><strong>Conclusions: </strong>Rescue treatment with daratumumab, carfilzomib, and/or pomalidomide was shown to be effective and safe in heavily pretreated patients with RRMM. PFS and OS were favorable compared to international studies, although the responses were less deep. These results are relevant for advocating the inclusion of these medications in the national health guarantees program, where treatment options for RRMM are very limited.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 4","pages":"246-253"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pelvic Exenteration in Rectal Cancer: A Paradigm That Must Change]. [盆腔切除治疗直肠癌:必须改变的模式]。
Pub Date : 2025-04-01 DOI: 10.4067/s0034-98872025000400316
Gonzalo Urrejola Schmied, José Tomás Larach Kattan, Cristián Jarry Trujillo, Bruno Nervi Nattero
{"title":"[Pelvic Exenteration in Rectal Cancer: A Paradigm That Must Change].","authors":"Gonzalo Urrejola Schmied, José Tomás Larach Kattan, Cristián Jarry Trujillo, Bruno Nervi Nattero","doi":"10.4067/s0034-98872025000400316","DOIUrl":"https://doi.org/10.4067/s0034-98872025000400316","url":null,"abstract":"","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 4","pages":"316-318"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical Approach to the Patient With Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis. Part I: Epidemiology, Diagnosis, and Prognostic Factors]. 史蒂文斯-约翰逊综合征合并中毒性表皮坏死松解症的临床分析。第一部分:流行病学,诊断和预后因素]。
Pub Date : 2025-04-01 DOI: 10.4067/s0034-98872025000400294
Nelson Lobos, Fernando Valenzuela, Monserrat Molgó, Valeska López, Francis Palisson

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe cutaneous manifestations of adverse drug reactions. This first review aims to provide an update on the epidemiological, pathophysiological, clinical manifestations, diagnostic, and prognostic aspects of these conditions.

Aim: To establish an updated clinical approach to SJS/TEN based on current evidence.

Methods: A search was conducted in indexed databases (PubMed, SciElo, LILACS), selecting 68 articles and 2 clinical guidelines from the Ministry of Health of Chile (MINSAL), from March to September 2024.

Results: SJS/TEN affects genetically susceptible individuals with inappropriate immune responses triggered by drugs or non-pharmacological factors, leading to keratinocyte apoptosis and high mortality. Three hypotheses for T-cell activation are proposed: hapten/prohapten, p-i interaction, and altered peptide model. Key mediators include FasL, perforins, granzymes, and granulysin. Genetic factors, such as HLA alleles and CYP450 variants, influence susceptibility. Diagnosis relies on clinical and histopathological evaluation. Skin biopsy is crucial for confirmation, though treatment should not be delayed if there is a high suspicion. Tools such as causality algorithms and developing biomarcadores may aid in early identification of SJS/TEN, though further research is needed.

Conclusions: Diagnosing Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is challenging due to their variable clinical presentations and similarities with differential diagnoses. Biopsy is essential, but histopathological findings do not always distinguish between forms of SJS and TEN. Causality assessment tools and advancements in biomarkers show potential, but further validation is needed. This initial review allows for understanding the rationale behind the recommendations outlined in the second part of the review.

史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解(TEN)是药物不良反应的严重皮肤表现。第一篇综述旨在提供这些疾病的流行病学、病理生理、临床表现、诊断和预后方面的最新情况。目的:基于现有证据,建立一种最新的SJS/TEN临床治疗方法。方法:检索检索数据库(PubMed, SciElo, LILACS),选择智利卫生部(MINSAL)于2024年3月至9月发布的68篇文献和2份临床指南。结果:SJS/TEN影响遗传易感个体,由药物或非药物因素引发不适当的免疫反应,导致角化细胞凋亡和高死亡率。提出了t细胞活化的三种假设:半抗原/前半抗原,p-i相互作用和改变的肽模型。关键的介质包括FasL、穿孔蛋白、颗粒酶和颗粒酶。遗传因素,如HLA等位基因和CYP450变异,影响易感性。诊断依赖于临床和组织病理学评估。皮肤活检是确诊的关键,但如果怀疑程度很高,不应延误治疗。因果关系算法等工具和开发生物中心可能有助于早期识别SJS/TEN,但需要进一步研究。结论:Stevens-Johnson综合征(SJS)和中毒性表皮坏死松解症(TEN)的诊断具有挑战性,因为它们的临床表现不同,且与鉴别诊断相似。活检是必要的,但组织病理学检查结果并不总是区分SJS和TEN的形式。因果关系评估工具和生物标志物的进步显示出潜力,但需要进一步验证。这一初步审查有助于了解审查第二部分概述的建议背后的理由。
{"title":"[Clinical Approach to the Patient With Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis. Part I: Epidemiology, Diagnosis, and Prognostic Factors].","authors":"Nelson Lobos, Fernando Valenzuela, Monserrat Molgó, Valeska López, Francis Palisson","doi":"10.4067/s0034-98872025000400294","DOIUrl":"https://doi.org/10.4067/s0034-98872025000400294","url":null,"abstract":"<p><p>Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe cutaneous manifestations of adverse drug reactions. This first review aims to provide an update on the epidemiological, pathophysiological, clinical manifestations, diagnostic, and prognostic aspects of these conditions.</p><p><strong>Aim: </strong>To establish an updated clinical approach to SJS/TEN based on current evidence.</p><p><strong>Methods: </strong>A search was conducted in indexed databases (PubMed, SciElo, LILACS), selecting 68 articles and 2 clinical guidelines from the Ministry of Health of Chile (MINSAL), from March to September 2024.</p><p><strong>Results: </strong>SJS/TEN affects genetically susceptible individuals with inappropriate immune responses triggered by drugs or non-pharmacological factors, leading to keratinocyte apoptosis and high mortality. Three hypotheses for T-cell activation are proposed: hapten/prohapten, p-i interaction, and altered peptide model. Key mediators include FasL, perforins, granzymes, and granulysin. Genetic factors, such as HLA alleles and CYP450 variants, influence susceptibility. Diagnosis relies on clinical and histopathological evaluation. Skin biopsy is crucial for confirmation, though treatment should not be delayed if there is a high suspicion. Tools such as causality algorithms and developing biomarcadores may aid in early identification of SJS/TEN, though further research is needed.</p><p><strong>Conclusions: </strong>Diagnosing Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is challenging due to their variable clinical presentations and similarities with differential diagnoses. Biopsy is essential, but histopathological findings do not always distinguish between forms of SJS and TEN. Causality assessment tools and advancements in biomarkers show potential, but further validation is needed. This initial review allows for understanding the rationale behind the recommendations outlined in the second part of the review.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 4","pages":"294-303"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment of Severe Lamotrigine Intoxication with Extracorporeal Therapy]. 重症拉莫三嗪中毒的体外治疗
Pub Date : 2025-04-01 DOI: 10.4067/s0034-98872025000400304
Hans Müller-Ortiz, Ricardo Fuentealba R, Vicente Torres-Cifuentes, Luciano Bravo P, Sandra Hernández S, Cristóbal Alvarado L

Lamotrigine is a drug that was initially used as an anticonvulsant and later its use was extended to mood disorders such as severe depression and bipolar disorder, being a safe drug with few adverse effects. Lamotrigine poisoning can present with mild symptoms such as palpitations and headache to more severe symptoms such as seizures, compromised consciousness, coma and cardiogenic shock. There is no described antidote for the treatment of this intoxication, so management is supportive; however, given the pharmacokinetic nature of the drug, extracorporeal therapies may be an option for severe cases. We present a case of severe lamotrigine poisoning managed with daily hemodialysis with a good clinical response.

拉莫三嗪是一种最初用作抗惊厥药的药物,后来它的用途扩展到情绪障碍,如严重抑郁症和双相情感障碍,作为一种安全的药物,几乎没有副作用。拉莫三嗪中毒可表现为轻微的症状,如心悸和头痛,更严重的症状,如癫痫发作、意识受损、昏迷和心源性休克。没有描述的解毒剂治疗这种中毒,所以管理是支持的;然而,考虑到药物的药代动力学性质,体外治疗可能是严重病例的一种选择。我们提出一个病例严重拉莫三嗪中毒管理与日常血液透析与良好的临床反应。
{"title":"[Treatment of Severe Lamotrigine Intoxication with Extracorporeal Therapy].","authors":"Hans Müller-Ortiz, Ricardo Fuentealba R, Vicente Torres-Cifuentes, Luciano Bravo P, Sandra Hernández S, Cristóbal Alvarado L","doi":"10.4067/s0034-98872025000400304","DOIUrl":"10.4067/s0034-98872025000400304","url":null,"abstract":"<p><p>Lamotrigine is a drug that was initially used as an anticonvulsant and later its use was extended to mood disorders such as severe depression and bipolar disorder, being a safe drug with few adverse effects. Lamotrigine poisoning can present with mild symptoms such as palpitations and headache to more severe symptoms such as seizures, compromised consciousness, coma and cardiogenic shock. There is no described antidote for the treatment of this intoxication, so management is supportive; however, given the pharmacokinetic nature of the drug, extracorporeal therapies may be an option for severe cases. We present a case of severe lamotrigine poisoning managed with daily hemodialysis with a good clinical response.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 4","pages":"304-309"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Anterior Thoracic Trichilemmal Carcinoma: A Rare Case with a Novel Treatment]. [胸前毛突癌:罕见病例及新治疗方法]。
Pub Date : 2025-04-01 DOI: 10.4067/s0034-98872025000400310
Claudio Escanilla, Claudia Schroder, Valentina Garrido, Merce Balague, Verónica Ruiz, José Ignacio Toscas, Carolina Cevallos

This report describes the case of a 97-year-old male patient, completely dependent on his activities of daily living (ECOG 3), with a 6-month-old tumor lesion in the anterior area of the chest. Skin biopsy informs a trichilemmal carcinoma. The patient received 5 weekly radiotherapy sessions of 7 Gy each (35 Gy total), with partial tumor response. It is intended to apply new sessions of radiotherapy to the affected area. The case is presented due to the low prevalenceand the dermoscopy findings of this type of carcinoma associated with a partial response to radiotherapy, a treatment rarely reported as first-line for this pathology.

本文报告一例97岁男性患者,完全依赖其日常生活活动(ECOG 3),胸部前部有6个月的肿瘤病变。皮肤活检提示滴管癌。患者每周接受5次放射治疗,每次7 Gy(总计35 Gy),肿瘤部分缓解。它的目的是将新的放射治疗应用于受影响的区域。由于这种类型的癌症的低患病率和皮肤镜检查结果与放射治疗的部分反应有关,这种治疗很少被报道为这种病理的一线治疗。
{"title":"[Anterior Thoracic Trichilemmal Carcinoma: A Rare Case with a Novel Treatment].","authors":"Claudio Escanilla, Claudia Schroder, Valentina Garrido, Merce Balague, Verónica Ruiz, José Ignacio Toscas, Carolina Cevallos","doi":"10.4067/s0034-98872025000400310","DOIUrl":"https://doi.org/10.4067/s0034-98872025000400310","url":null,"abstract":"<p><p>This report describes the case of a 97-year-old male patient, completely dependent on his activities of daily living (ECOG 3), with a 6-month-old tumor lesion in the anterior area of the chest. Skin biopsy informs a trichilemmal carcinoma. The patient received 5 weekly radiotherapy sessions of 7 Gy each (35 Gy total), with partial tumor response. It is intended to apply new sessions of radiotherapy to the affected area. The case is presented due to the low prevalenceand the dermoscopy findings of this type of carcinoma associated with a partial response to radiotherapy, a treatment rarely reported as first-line for this pathology.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 4","pages":"310-313"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparative Analysis of Mental Health in Chilean Bisexual Individuals and Their Gay, Lesbian, and Heterosexual Counterparts]. [智利双性恋者与男同性恋、女同性恋和异性恋者的心理健康比较分析]。
Pub Date : 2025-04-01 DOI: 10.4067/s0034-98872025000400268
Mónica Guzmán-González, Jaime Barrientos, Joaquín Bahamondes

International studies show that bisexual people tend to experience higher levels of mental health problems than gays, lesbians, and heterosexuals. However, there is little research on this group in the Latin American and Chilean context.

Aim: To describe and compare the mental health of bisexual women and men in Chile, with respect to their gay, lesbian and heterosexual counterparts.

Materials and method: A stratified and multistage probabilistic sample of 20,392 people aged 18 years and over, residing in urban areas of Chile, obtained through the Second National Survey on Health, Sexuality, and Gender (ENSSEX-2022) was used. Participants completed a 305-question survey, including the Patient Health Questionnaire-4 (PHQ-4) to assess depressive and anxiety symptomatology, and a question to assess sexual orientation. Weighted linear regression models were performed to compare levels of depression and anxiety between different sexual orientation groups, using bisexual women as the reference group. The variables of age and educational level were controlled.

Results: The analyses revealed that bisexual women reported significantly higher scores on depressive and anxious symptoms compared to the other groups (heterosexual women, heterosexual men, lesbian women, gay men), except for bisexual men, who also exhibited high levels in both variables.

Conclusions: Our study provides information that can support public policies, support and awareness programs, as well as the promotion of equality towards different sexual orientations, with a particular focus on bisexual women.

国际研究表明,双性恋者比男同性恋、女同性恋和异性恋者更容易出现心理健康问题。然而,在拉丁美洲和智利的背景下,对这一群体的研究很少。目的:描述和比较智利双性恋男女与男同性恋、女同性恋和异性恋者的心理健康状况。材料和方法:通过第二次全国健康、性和性别调查(ENSSEX-2022),对居住在智利城市地区的20,392名18岁及以上的人进行了分层和多阶段概率抽样。参与者完成了一项305个问题的调查,其中包括评估抑郁和焦虑症状的患者健康问卷-4 (PHQ-4),以及评估性取向的问题。以双性恋女性为参照组,采用加权线性回归模型比较不同性取向人群的抑郁和焦虑水平。控制年龄、文化程度等变量。结果:分析显示,双性恋女性在抑郁和焦虑症状上的得分明显高于其他群体(异性恋女性、异性恋男性、女同性恋女性、男同性恋),除了双性恋男性,他们在这两个变量上也表现得很高。结论:我们的研究提供的信息可以支持公共政策,支持和意识项目,以及促进不同性取向的平等,特别是对双性恋女性的关注。
{"title":"[Comparative Analysis of Mental Health in Chilean Bisexual Individuals and Their Gay, Lesbian, and Heterosexual Counterparts].","authors":"Mónica Guzmán-González, Jaime Barrientos, Joaquín Bahamondes","doi":"10.4067/s0034-98872025000400268","DOIUrl":"https://doi.org/10.4067/s0034-98872025000400268","url":null,"abstract":"<p><p>International studies show that bisexual people tend to experience higher levels of mental health problems than gays, lesbians, and heterosexuals. However, there is little research on this group in the Latin American and Chilean context.</p><p><strong>Aim: </strong>To describe and compare the mental health of bisexual women and men in Chile, with respect to their gay, lesbian and heterosexual counterparts.</p><p><strong>Materials and method: </strong>A stratified and multistage probabilistic sample of 20,392 people aged 18 years and over, residing in urban areas of Chile, obtained through the Second National Survey on Health, Sexuality, and Gender (ENSSEX-2022) was used. Participants completed a 305-question survey, including the Patient Health Questionnaire-4 (PHQ-4) to assess depressive and anxiety symptomatology, and a question to assess sexual orientation. Weighted linear regression models were performed to compare levels of depression and anxiety between different sexual orientation groups, using bisexual women as the reference group. The variables of age and educational level were controlled.</p><p><strong>Results: </strong>The analyses revealed that bisexual women reported significantly higher scores on depressive and anxious symptoms compared to the other groups (heterosexual women, heterosexual men, lesbian women, gay men), except for bisexual men, who also exhibited high levels in both variables.</p><p><strong>Conclusions: </strong>Our study provides information that can support public policies, support and awareness programs, as well as the promotion of equality towards different sexual orientations, with a particular focus on bisexual women.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 4","pages":"268-278"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ricarte Soto Law, A Unique Case Study for Reflection]. [Ricarte Soto Law,反思的独特案例研究]。
Pub Date : 2025-04-01 DOI: 10.4067/s0034-98872025000400279
María Angélica Saldías-Fernández, Claudia Rodríguez-Torres, Denisse Parra-Giordano

The high cost of health procedures can cause financial problems for individuals and their families, becoming a catastrophic expense when it exceeds 40% of the family budget. In this regard, in Chile in 2015, Law 20,850 was enacted, which provides a Financial Protection System for High-Cost Diagnoses and Treatments.

Aim: Analyze the phenomenon of study based on the modeling of the existing literature around the public policy of the Ricarte Soto Law in its formulation process.

Methodology: Idiographic case study mediated by a theoretical and empirical, transdisciplinary documentary review; bibliographic search (2010-2023, English and Spanish languages) on the concepts related to this public policy. After the theoretical analysis, the information is classified according to the stages of public policy formulation; six indicators are grouped into three dimensions: resources, conflict, and impact, according to Pechmann.

Results: 50 articles were analyzed. The Ricarte Soto Law creates a financial protection system for the diagnosis and treatment of high-cost diseases; from its formulation to its implementation as a public health policy in 2015, it has revealed some strengths and complexities that have impacted said protection, covering 27 pathologies at this moment.

Conclusion: In recent years, there has been an increase in interest on the part of health systems in implementing more transparent, ethical, scientific, evidence-based decision-making processes for the coverage of these diseases. In this, the case study presented allowed to analyze the formulation of the public policy of the Ricarte Soto law, as well as present different opportunities for improvement in the face of the current threats of the socio-political environment and sociodemographic challenges.

医疗程序的高成本可能会给个人及其家庭带来经济问题,当它超过家庭预算的40%时,就会成为一项灾难性的支出。在这方面,智利于2015年颁布了第20,850号法律,该法律为高成本诊断和治疗提供了财务保护制度。目的:在对现有文献进行建模的基础上,对《索托法》制定过程中的公共政策研究现象进行分析。方法:具体案例研究,通过理论和实证,跨学科文献回顾;参考文献检索(2010-2023,英语和西班牙语)关于这一公共政策的相关概念。经过理论分析,将信息按照公共政策制定的阶段进行分类;根据Pechmann的说法,六个指标分为三个维度:资源、冲突和影响。结果:共分析了50篇文献。《李嘉图·索托法》为高费用疾病的诊断和治疗建立了财政保护制度;从它的制定到2015年作为一项公共卫生政策的实施,它揭示了影响上述保护的一些优势和复杂性,目前涵盖了27种病理。结论:近年来,卫生系统越来越有兴趣在这些疾病的覆盖方面实施更加透明、合乎道德、科学和循证的决策过程。在这方面,提出的案例研究允许分析Ricarte Soto法的公共政策的制定,以及在面对当前社会政治环境和社会人口挑战的威胁时提出不同的改进机会。
{"title":"[Ricarte Soto Law, A Unique Case Study for Reflection].","authors":"María Angélica Saldías-Fernández, Claudia Rodríguez-Torres, Denisse Parra-Giordano","doi":"10.4067/s0034-98872025000400279","DOIUrl":"10.4067/s0034-98872025000400279","url":null,"abstract":"<p><p>The high cost of health procedures can cause financial problems for individuals and their families, becoming a catastrophic expense when it exceeds 40% of the family budget. In this regard, in Chile in 2015, Law 20,850 was enacted, which provides a Financial Protection System for High-Cost Diagnoses and Treatments.</p><p><strong>Aim: </strong>Analyze the phenomenon of study based on the modeling of the existing literature around the public policy of the Ricarte Soto Law in its formulation process.</p><p><strong>Methodology: </strong>Idiographic case study mediated by a theoretical and empirical, transdisciplinary documentary review; bibliographic search (2010-2023, English and Spanish languages) on the concepts related to this public policy. After the theoretical analysis, the information is classified according to the stages of public policy formulation; six indicators are grouped into three dimensions: resources, conflict, and impact, according to Pechmann.</p><p><strong>Results: </strong>50 articles were analyzed. The Ricarte Soto Law creates a financial protection system for the diagnosis and treatment of high-cost diseases; from its formulation to its implementation as a public health policy in 2015, it has revealed some strengths and complexities that have impacted said protection, covering 27 pathologies at this moment.</p><p><strong>Conclusion: </strong>In recent years, there has been an increase in interest on the part of health systems in implementing more transparent, ethical, scientific, evidence-based decision-making processes for the coverage of these diseases. In this, the case study presented allowed to analyze the formulation of the public policy of the Ricarte Soto law, as well as present different opportunities for improvement in the face of the current threats of the socio-political environment and sociodemographic challenges.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 4","pages":"279-293"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Molecularly Imprinted Polymer: A New Technology for Diagnosing Colorectal Cancer]. 分子印迹聚合物:一种诊断结直肠癌的新技术
Pub Date : 2025-04-01 DOI: 10.4067/s0034-98872025000400314
Sofía Hernández Umaña, Sebastián A Correa
{"title":"[Molecularly Imprinted Polymer: A New Technology for Diagnosing Colorectal Cancer].","authors":"Sofía Hernández Umaña, Sebastián A Correa","doi":"10.4067/s0034-98872025000400314","DOIUrl":"https://doi.org/10.4067/s0034-98872025000400314","url":null,"abstract":"","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 4","pages":"314-315"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 2017 National Health Survey on Biomonitoring of Metals associates Higher Arsenic Levels with Age, Sex, Geography, and Fish Consumption. 2017年全国金属生物监测健康调查显示,较高的砷含量与年龄、性别、地理位置和鱼类消费有关。
Pub Date : 2025-04-01 DOI: 10.4067/s0034-98872025000400254
Patricio Medel-Jara, Fabio Paredes, Patricia Cerda, Daniel Rebolledo, Marli Bettini, Sandra Solari, Johanna Acevedo, Juan Carlos Ríos Bustamante

This study investigates the exposure of the Chilean population to heavy metals, specifically arsenic, lead, mercury, and cadmium, using data from the 2016-2017 National Health Survey (NHS). Chronic exposure to these metals poses significant health risks, including cancer, cardiovascular diseases, and neurological effects.

Aim: The study aims to analyze metal levels across different demographics and identify factors associated with elevated exposure.

Methods: A cross-sectional analysis was conducted using NHS data, which includes metal levels in blood and urine, alongside demographic, socioeconomic, and lifestyle information. The sample consisted of 3.600 participants aged 18 and older. Metal levels were measured using mass spectrometry and spectrophotometry. Statistical analyses, including quantile and logistic regression, were performed to assess the impact of various covariates on metal levels.

Results: The study found that 91.04% of the population had arsenic levels below the reference value of 35 pg/L, while 8.45% had levels between 35 and 100 pg/L, and 0.51% exceeded 100 pg/L. Elevated arsenic levels were associated with younger age, male sex, rural residence, northern macrozone, and high fish consumption. Lead, mercury, and cadmium levels were generally within limits, with notable variations based on age, sex, and geographic region.

Conclusion: The findings highlight significant arsenic exposure in certain demographics, necessitating targeted public health interventions. While lead, mercury, and cadmium levels are mostly within limits, ongoing biomonitoring and public awareness are crucial to mitigate health risks. The study underscores the importance of tailored policies to reduce metal exposure and protect vulnerable populations in Chile.

本研究使用2016-2017年全国健康调查(NHS)的数据,调查了智利人口对重金属的暴露情况,特别是砷、铅、汞和镉。长期接触这些金属会造成重大的健康风险,包括癌症、心血管疾病和神经系统影响。目的:该研究旨在分析不同人口统计数据中的金属水平,并确定与接触量增加相关的因素。方法:使用NHS数据进行横断面分析,其中包括血液和尿液中的金属水平,以及人口统计学,社会经济和生活方式信息。样本由3600名18岁及以上的参与者组成。采用质谱法和分光光度法测定金属含量。统计分析,包括分位数和逻辑回归,评估各种协变量对金属水平的影响。结果:研究发现,91.04%的人群砷水平低于参考值35 pg/L, 8.45%的人群砷水平在35 ~ 100 pg/L之间,0.51%的人群砷水平超过100 pg/L。砷含量升高与年龄较小、男性、农村居住、北部宏观经济区和高鱼类消费有关。铅、汞和镉水平总体上在限制范围内,根据年龄、性别和地理区域存在显著差异。结论:研究结果强调在某些人口统计中存在显著的砷暴露,需要有针对性的公共卫生干预措施。虽然铅、汞和镉的含量大多在限制范围内,但持续的生物监测和公众意识对于减轻健康风险至关重要。该研究强调了制定有针对性的政策以减少金属暴露和保护智利弱势群体的重要性。
{"title":"The 2017 National Health Survey on Biomonitoring of Metals associates Higher Arsenic Levels with Age, Sex, Geography, and Fish Consumption.","authors":"Patricio Medel-Jara, Fabio Paredes, Patricia Cerda, Daniel Rebolledo, Marli Bettini, Sandra Solari, Johanna Acevedo, Juan Carlos Ríos Bustamante","doi":"10.4067/s0034-98872025000400254","DOIUrl":"https://doi.org/10.4067/s0034-98872025000400254","url":null,"abstract":"<p><p>This study investigates the exposure of the Chilean population to heavy metals, specifically arsenic, lead, mercury, and cadmium, using data from the 2016-2017 National Health Survey (NHS). Chronic exposure to these metals poses significant health risks, including cancer, cardiovascular diseases, and neurological effects.</p><p><strong>Aim: </strong>The study aims to analyze metal levels across different demographics and identify factors associated with elevated exposure.</p><p><strong>Methods: </strong>A cross-sectional analysis was conducted using NHS data, which includes metal levels in blood and urine, alongside demographic, socioeconomic, and lifestyle information. The sample consisted of 3.600 participants aged 18 and older. Metal levels were measured using mass spectrometry and spectrophotometry. Statistical analyses, including quantile and logistic regression, were performed to assess the impact of various covariates on metal levels.</p><p><strong>Results: </strong>The study found that 91.04% of the population had arsenic levels below the reference value of 35 pg/L, while 8.45% had levels between 35 and 100 pg/L, and 0.51% exceeded 100 pg/L. Elevated arsenic levels were associated with younger age, male sex, rural residence, northern macrozone, and high fish consumption. Lead, mercury, and cadmium levels were generally within limits, with notable variations based on age, sex, and geographic region.</p><p><strong>Conclusion: </strong>The findings highlight significant arsenic exposure in certain demographics, necessitating targeted public health interventions. While lead, mercury, and cadmium levels are mostly within limits, ongoing biomonitoring and public awareness are crucial to mitigate health risks. The study underscores the importance of tailored policies to reduce metal exposure and protect vulnerable populations in Chile.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 4","pages":"254-267"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista medica de Chile
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1